Postgraduate Course

Ulcerative Colitis Update 2019

Speaker(s)

• 

  David Rubin, MD, FACG

  Joseph B. Kirsner Professor of Medicine; Chief, Section of Gastroenterology, Hepatology and Nutrition; Co-Director, Digestive Diseases Center
  University of Chicago Medicine
  Chicago, IL, US

  Advisory Committee/Board Member: Janssen
  Consultant: AbbVie, Abgenomics, Allergan, Arena Pharmaceuticals, Biomica, Bristol-Myers Squibb, Ferring Pharmaceuticals, Genentech, Janssen, Lilly, Medtronic, Merck, Napo Pharmaceuticals, Pfizer, Shire, Takeda, Target PharmaSolutions, Inc.
  Grant/Research Support: AbbVie, Genentech, Prometheus Laboratories, Shire, Takeda
  

Learning Objectives:

• Describe the important adverse events that can occur with the use of biologic therapy.